Meloxicam Capsule 15 mg (Meloxicam)

Adult dose

1. Acute exacerbations of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to 15 mg daily as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of this medication orally once daily. The dose may be reduced to 7.5 mg daily according to the response to treatment. Do not administer more than 15 mg of this medication per day. Take it with water or another beverage during a meal. ○ In elderly patients or those at increased risk of adverse reactions, treatment is usually started at a dose of 7.5 mg daily. ○ Patients with severe renal impairment receiving hemodialysis should not receive more than 7.5 mg daily.

This medication may pose a risk of gastrointestinal bleeding if taken by someone who regularly consumes more than three drinks a day, so consultation with a doctor or pharmacist is essential. This medication can increase the risk of cardiovascular disease, so those with a history of heart disease or stroke, or risk factors, should be monitored closely. If symptoms such as chest pain, shortness of breath, weakness, or stuttering occur, this medication should be discontinued immediately. This medication can cause serious gastrointestinal issues such as gastrointestinal bleeding, ulcers, or perforation, so those with a history of gastrointestinal diseases or the elderly should be particularly careful. If gastrointestinal symptoms or signs of bleeding occur, immediate medical evaluation and treatment are necessary, and alternative treatments should be considered for high-risk groups. This medication can cause serious skin reactions or life-threatening allergic reactions, so if there are any skin abnormalities, use should be stopped immediately. Patients with certain diseases such as impaired kidney function, liver dysfunction, congestive heart failure, hypertension, etc., require careful observation when taking this medication. Women planning to become pregnant or who may be pregnant should not take this medication as it may reduce reproductive ability. This medication should not be administered to adolescents under 15 years of age, patients with severe liver impairment, severe kidney impairment, severe congestive heart failure, or severe hypertension. Due to many interactions with other medications, especially anticoagulants, lithium, methotrexate, diuretics, and antihypertensive agents, consultation with a doctor is recommended if any of these are being taken. It should never be taken during pregnancy as it can have severe effects on the fetus, and should also not be used while breastfeeding. The elderly should take the lowest effective dose carefully and should be closely monitored for adverse reactions due to weakened kidney, liver, and heart functions. In case of overdose, symptoms such as nausea, vomiting, and gastrointestinal bleeding may occur, and immediate treatment at a hospital is necessary. This medication should be kept out of the reach of children and stored sealed in its original container.

• Gastrointestinal bleeding
• cardiovascular thromboembolic reactions
• myocardial infarction
• stroke
• bleeding from the stomach or intestine
• ulcers
• perforation
• exfoliative dermatitis
• Stevens-Johnson syndrome
• toxic epidermal necrolysis

This medication is sensitive to light, so it should be stored in a container that protects it from light. Additionally, it should be stored at a temperature between 1 to 30 degrees Celsius in a safe manner.

Appearance

A hard capsule with a green upper part and a pale yellow lower part containing a yellowish powder.

Package unit

30 capsules/bottle, 100 capsules/bottle